InsidersTradesSigma
Discover the complete record of transactions filed by Jakob Knudsen, Director. Director active across 2 companies, notably Expres2ion Biotech Holding AB. Cumulatively, 1 disclosures have been logged. The latest transaction was disclosed on 6 May 2026 — Purchase. Regulator: FIN-FSA. The full history is openly available.
1 of 1 declaration
Jakob Knudsen is a Board Member at Expres2ion Biotech Holding AB. He contributes to the governance of the company and strategic decision-making. His experience is valuable for Expres2ion's development.